NEURO-INTERVENTIONAL DEVICES MARKET ANALYSIS

Neuro-interventional Devices Market, By Product Type (Embolization Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy, Flow Disruption, Flow Diverters,, Intrasaccular Devices, Liquid Embolic Coils, Balloons, Stent Retrievers), By Technique (Neurothrombectomy Procedure, Cerebral Angiography, Stenting, Coiling Procedures, Flow Disruption), By End User (Hospitals, Clinics, Ambulatory Surgical Centers), By geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Global Neuro-interventional Devices Market: Key Developments

In May 2023, Stryker Corporation, a medical technologies company, announced that it had completed the acquisition of Cerus Endovascular Ltd., a company developing neurointerventional devices and delivery systems for the treatment of intracranial aneurysms.
In September 2022, NeuroVasc Technologies, a medical device company, announced that the first patient had been treated in ENVI RCT, the NeuroVasc Envi-SR randomized controlled trial for endovascular treatment of ischemic stroke in the clinical trials. Envi-SR is a stent-retriever device is intended for the treatment of acute ischemic stroke.
In February 2022, Peijia Medical Limited, a medical device company developing neuro-interventional procedural medical devices, announced that it had received approval for the registration application of company’s Syphonet Stent Retriever from National Medical Products Administration (NMPA). It is the company’s eleventh NMPA approved neuro-interventional product.